FDA Announces Approval of Information Collection for Electronic Records and Signatures

Summary

The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) to collect information related to electronic records and signatures, as part of its efforts to streamline the approval process for direct-to-consumer prescription drug advertising.